1. Overuse and misuse in human medicine
Every course of antibiotics applies selection pressure, so unnecessary courses breed resistance while delivering no benefit. Studies in high-income countries consistently find that a large share of antibiotic prescriptions — commonly estimated at around 30% in US outpatient care, and up to half by some measures — are unnecessary or suboptimal, often given for viral illnesses such as colds, flu and most sore throats, against which antibiotics do nothing.
- Prescribing without diagnostics. Where rapid tests are unavailable or unused, clinicians prescribe “just in case”, and broad-spectrum drugs are chosen when a narrow one would do.
- Over-the-counter sales. In many countries antibiotics can still be bought without a prescription, encouraging self-medication with wrong drugs, doses and durations.
- Patient pressure and time pressure. A prescription is often the fastest way to end a consultation.
- Substandard and falsified medicines. Under-strength or fake antibiotics — a significant problem in parts of Africa and Asia — expose bacteria to sub-lethal doses, the ideal recipe for selecting resistance.
2. Massive use in food animals
By most estimates, animals — not people — consume the majority of the world's antimicrobials: roughly 70–73% of all antibiotics sold globally are used in food-producing animals, often given to whole healthy herds and flocks to prevent disease in crowded conditions or, historically, simply to make animals grow faster.
- Global veterinary antimicrobial consumption is projected to reach around 104,000 tonnes by 2030, up more than 11% from 2017.
- The EU banned antibiotic growth promoters in 2006 and since 2022 also bans routine preventive mass medication, but practices vary widely: farm antibiotic sales per livestock unit in parts of Asia-Pacific are roughly four times higher than in Europe.
- Resistant bacteria selected on farms — such as resistant Salmonella, Campylobacter and E. coli — reach people through food, direct contact and water. The mcr-1 colistin-resistance gene was first found in Chinese pigs before appearing in patients worldwide.
- Aquaculture and crop spraying (antibiotics are even used on fruit orchards in some countries) add further, poorly monitored selection pressure.
3. Poor infection prevention, sanitation and vaccination gaps
Every infection prevented is an antibiotic course avoided. The reverse is also true: where clean water, sanitation, hygiene and vaccines are lacking, infections multiply — and so does antibiotic use and resistance.
- Hospitals concentrate vulnerable patients, invasive devices and heavy antibiotic use, making them incubators for resistant organisms; weak infection control lets those organisms spread between patients.
- Unsafe water and sanitation drive diarrhoeal disease, a major source of (often inappropriate) antibiotic use in low- and middle-income countries.
- Underused vaccines matter twice over: vaccines against bacterial diseases (pneumococcus, typhoid, Hib) directly prevent infections that would need antibiotics, and vaccines against viral illness (like flu) prevent the mistaken antibiotic prescriptions that often follow.
4. Environmental contamination
The environment is the often-forgotten third leg of the problem. Antibiotic residues, resistant bacteria and resistance genes enter soil and water through human sewage, farm run-off and — at hotspots — waste from pharmaceutical manufacturing, where antibiotic concentrations in effluent can exceed levels found in the blood of treated patients. Rivers and wastewater act as mixing vessels where environmental bacteria, human pathogens and resistance genes meet and trade DNA.
5. A broken market for new antibiotics
While resistance rises, the supply of new drugs has stalled. Antibiotics are cheap, taken briefly, and — if new and precious — deliberately held in reserve, so they earn little. Most major pharmaceutical companies abandoned antibacterial research decades ago, and several small biotechs have gone bankrupt after successfully getting a new antibiotic approved. Fixing these incentives is a central theme of the global response and innovation pages.
Accelerants: travel, conflict and pandemics
International travel and trade move resistant organisms between continents in hours. Conflict zones combine wounds, collapsed health systems and unregulated antibiotic use — highly resistant strains have spread from recent war zones. The COVID-19 pandemic made things worse too: large numbers of hospitalised patients received antibiotics they did not need, and US data showed resistant hospital infections and deaths jumping about 15% in 2020.
Why this is a “One Health” problem
Human medicine, animal farming and the environment form one connected reservoir of microbes and genes. Action in only one sector gets undone by the other two — which is why WHO, the UN's food and agriculture bodies (FAO), the World Organisation for Animal Health (WOAH) and the UN Environment Programme now tackle AMR jointly under the banner of One Health.
Sources for this page
- “Antibiotic Use in Livestock and Environmental Antibiotic Resistance: A Narrative Review”, Environmental Health Insights, 2025 — bioone.org/journals/environmental-health-insights
- “Livestock Antibiotics Use and Antimicrobial Resistance”, PMC, 2025 — pmc.ncbi.nlm.nih.gov/articles/PMC12189104/
- Alliance to Save Our Antibiotics, “Antibiotic Overuse in Livestock Farming” — saveourantibiotics.org
- CDC, “COVID-19: U.S. Impact on Antimicrobial Resistance”, Special Report 2022 — cdc.gov
- WHO fact sheet, “Antimicrobial resistance” — who.int/news-room/fact-sheets/detail/antimicrobial-resistance